Series A funding round for Switch Therapeutics raising $52M in March 2023
Series A funding round for Switch Therapeutics raising $52M in March 2023
| Investor | Firm Type | Partner |
|---|
Insight PartnersLEAD | Venture Capital | — |
UCBLEAD | Private | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Public | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Corporate Venture Capital | — | |
| Angel | Eli Lilly |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$52M
Top Valuation
-
Switch Therapeutics raised $52M in a Series A round.
The round was announced on 03/01/23.
The round was led by Insight Partners, Alicia Iruzun Lafitte.